Improvement of stiff-person syndrome symptoms in pregnancy: Case series and literature review

Conclusions The immune pathogenesis of SPS continues to be explored. Immunomodulatory shifts during pregnancy may influence changes of clinical SPS symptoms and provide insight into the unique pathogenesis of SPS. Some women with SPS may be able to reduce symptomatic medications related to clinical improvement during pregnancy. Women with SPS may safely carry pregnancies to term, delivering healthy and unaffected babies.

http://nn.neurology.org/cgi/content/short/7/3/e684?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - February 24, 2020 Category: Neurology Authors: Esch, M. E., Newsome, S. D. Tags: Autoimmune diseases, Stiff person syndrome Article Source Type: research